Get my own profile
Public access
View all16 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Bulent Arman AksoyObsidian TherapeuticsVerified email at aksoy.org
- Alex RubinsteynUniversity of North Carolina - Chapel HillVerified email at openvax.org
- Arun AhujaGoogle Deepmind, Mount Sinai School of Medicine, Northwestern UniversityVerified email at google.com
- Timothy O'DonnellMount Sinai School of MedicineVerified email at mssm.edu
- Tavi NathansonSequence SoftwareVerified email at sequencesoftware.io
- Uri LasersonGinkgo BioworksVerified email at ginkgobioworks.com
- Pinar AksoyScientist at Alloy TherapeuticsVerified email at aksoy.org
- Matthew HellmannMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
- Taha MerghoubAssociate Professor, MSKVerified email at mskcc.org
- Jacqueline BurosGenerableVerified email at generable.com
- Chrystal PaulosEmory UniversityVerified email at emory.edu
- Julia KodyshOpenVax @ Icahn School of Medicine at Mount SinaiVerified email at openvax.org
- John P. Finnigan, Jr.Brigham and Women's HospitalVerified email at bwh.harvard.edu
- Marissa VignaliSenior Manager, Research and Business Development, Adaptive BiotechnologiesVerified email at adaptivebiotech.com
- Erik C. YuskoAdaptive BiotechnologiesVerified email at adaptivebiotech.com
- Elaine MardisOhio State UniversityVerified email at nationwidechildrens.org
- Hikmat Al-AhmadieMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
- Gopa IyerMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
- Jonathan RosenbergAttending Physician, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
- Eliezer Van AllenDana-Farber Cancer InstituteVerified email at dfci.harvard.edu